BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21409742)

  • 1. [Complications of pelvic lymphadenectomy in clinically localised prostate cancer: different techniques in comparison and dependency on the number of removed lymph nodes].
    Winter A; Vogt C; Weckermann D; Wawroschek F
    Aktuelle Urol; 2011 May; 42(3):179-83. PubMed ID: 21409742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
    Heidenreich A; Ohlmann CH; Polyakov S
    Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population.
    Sengupta S; Weerakoon M; Sethi K; Ischia J; Webb DR
    BJU Int; 2012 Apr; 109 Suppl 3():48-51. PubMed ID: 22458494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: implications for compliance with existing guidelines.
    Eden CG; Zacharakis E; Bott S
    BJU Int; 2013 Aug; 112(3):346-54. PubMed ID: 23419154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended pelvic lymphadenectomy for prostate cancer: will the previously reported benefits be reproduced in hospitals with lower surgical volumes?
    Lindberg C; Davidsson T; Gudjónsson S; Hilmarsson R; Liedberg F; Bratt O
    Scand J Urol Nephrol; 2009; 43(6):437-41. PubMed ID: 19707953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.
    Bastide C; Brenot-Rossi I; Garcia S; Rossi D
    Eur J Surg Oncol; 2009 Jul; 35(7):751-6. PubMed ID: 18538526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
    Eden CG; Arora A; Rouse P
    BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
    Lattouf JB; Beri A; Jeschke S; Sega W; Leeb K; Janetschek G
    Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: Assessing nodal yield, perioperative outcomes, and complications.
    Zorn KC; Katz MH; Bernstein A; Shikanov SA; Brendler CB; Zagaja GP; Shalhav AL
    Urology; 2009 Aug; 74(2):296-302. PubMed ID: 19515403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.
    Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G
    Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes.
    Sagalovich D; Calaway A; Srivastava A; Sooriakumaran P; Tewari AK
    BJU Int; 2013 Jan; 111(1):85-94. PubMed ID: 22823452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
    Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
    BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram.
    Kazzazi A; Djavan B
    Can J Urol; 2011 Apr; 18(2):5585-91. PubMed ID: 21504645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications.
    Capitanio U; Pellucchi F; Gallina A; Briganti A; Suardi N; Salonia A; Abdollah F; Di Trapani E; Jeldres C; Cestari A; Karakiewicz PI; Montorsi F
    BJU Int; 2011 Apr; 107(7):1095-101. PubMed ID: 20880192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.